Measuring autophagy level along with vaccine reactive IFN-+CD4+ Th1 cells may be a promising approach to understand effi cacy of anti TB vaccine(s)
Open Access
- 21 March 2018
- journal article
- Published by Peertechz Publications Private Limited in Journal of Vaccines and Immunology
- Vol. 4 (1), 001-003
- https://doi.org/10.17352/jvi.000022
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Under Performance of Anti Tuberculosis Vaccine MVA85A in BCGPrimed Subjects: A CommentaryCurrent Immunology Reviews, 2016
- Anti Tuberculosis Vaccine and Autophagy: A Possible Platform to Improve the Performance of VaccineJournal of Infectious Pulmonary Diseases, 2015
- Clinical Immunology and Multiplex Biomarkers of Human TuberculosisCold Spring Harbor Perspectives in Medicine, 2014
- Autophagy enhances the Efficacy of BCG VaccinePublished by Wiley ,2014
- Vaccine against tuberculosis: a viewJournal of Medical Microbiology, 2014
- How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis?International Journal of Mycobacteriology, 2014
- Tuberculosis vaccines: Time to think about the next generationSeminars in Immunology, 2013
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialThe Lancet, 2013
- Fundamentals of vaccine immunologyJournal of Global Infectious Diseases, 2011
- Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected MacrophagesCell, 2004